These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 16877496)

  • 81. On the role of Volterra integral equations in self-consistent, product-limit, inverse probability of censoring weighted, and redistribution-to-the-right estimators for the survival function.
    Strawderman RL; Baer BR
    Lifetime Data Anal; 2024 Jul; 30(3):649-666. PubMed ID: 38512595
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Estimation of attributable fractions using inverse probability weighting.
    Sjölander A
    Stat Methods Med Res; 2011 Aug; 20(4):415-28. PubMed ID: 20223785
    [TBL] [Abstract][Full Text] [Related]  

  • 83. The exponentiated exponential mixture and non-mixture cure rate model in the presence of covariates.
    Mazucheli J; Coelho-Barros EA; Achcar JA
    Comput Methods Programs Biomed; 2013 Oct; 112(1):114-24. PubMed ID: 23932336
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Efficient analysis of Weibull survival data from experiments on heterogeneous patient populations.
    Williams JS
    Biometrics; 1978 Jun; 34(2):209-22. PubMed ID: 667270
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Non-crossing weighted kernel quantile regression with right censored data.
    Bang S; Eo SH; Cho YM; Jhun M; Cho H
    Lifetime Data Anal; 2016 Jan; 22(1):100-21. PubMed ID: 25511333
    [TBL] [Abstract][Full Text] [Related]  

  • 86. On logistic regression with right censored data, with or without competing risks, and its use for estimating treatment effects.
    Blanche PF; Holt A; Scheike T
    Lifetime Data Anal; 2023 Apr; 29(2):441-482. PubMed ID: 35799026
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Estimating the quantile medical cost under time-dependent covariates and right censored time-to-event variable based on a state process.
    Liu X; Deng D; Wang D
    Stat Methods Med Res; 2020 Aug; 29(8):2041-2062. PubMed ID: 31640484
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Nonparametric estimation of marked survival data in the presence of dependent censoring.
    Sanusi B; Cai J; Hudgens MG
    Stat Med; 2023 May; 42(12):1995-2008. PubMed ID: 36945185
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Statistical analysis of data from dilution assays with censored correlated counts.
    Quiroz J; Wilson JR; Roychoudhury S
    Pharm Stat; 2012; 11(1):63-73. PubMed ID: 22275293
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Optimal estimation for regression models on τ-year survival probability.
    Kwak M; Kim J; Jung SH
    J Biopharm Stat; 2015; 25(3):539-47. PubMed ID: 24897607
    [TBL] [Abstract][Full Text] [Related]  

  • 91. A transformation approach for the analysis of interval-censored failure time data.
    Zhu L; Tong X; Sun J
    Lifetime Data Anal; 2008 Jun; 14(2):167-78. PubMed ID: 18165933
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Testing for bias in weighted estimating equations.
    Lipsitz S; Parzen M; Molenberghs G; Ibrahim J
    Biostatistics; 2001 Sep; 2(3):295-307. PubMed ID: 12933540
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Dimension reduction and graphical exploration in regression including survival analysis.
    Cook RD
    Stat Med; 2003 May; 22(9):1399-413. PubMed ID: 12704605
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Generalized Redistribute-to-the-Right Algorithm: Application to the Analysis of Censored Cost Data.
    Chen S; Zhao H
    J Stat Theory Pract; 2013 Apr; 7(2):. PubMed ID: 24403869
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Testing equality of survival functions of quality-adjusted lifetime.
    Zhao H; Tsiatis AA
    Biometrics; 2001 Sep; 57(3):861-7. PubMed ID: 11550938
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Estimating differences in restricted mean lifetime using observational data subject to dependent censoring.
    Zhang M; Schaubel DE
    Biometrics; 2011 Sep; 67(3):740-9. PubMed ID: 21039400
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Tree-structured survival analysis.
    Gordon L; Olshen RA
    Cancer Treat Rep; 1985 Oct; 69(10):1065-9. PubMed ID: 4042086
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Median regression with censored cost data.
    Bang H; Tsiatis AA
    Biometrics; 2002 Sep; 58(3):643-9. PubMed ID: 12229999
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Joint regression analysis of survival and quality-adjusted survival.
    Fine JP; Gelber RD
    Biometrics; 2001 Jun; 57(2):376-82. PubMed ID: 11414559
    [TBL] [Abstract][Full Text] [Related]  

  • 100. A comparison of several methods of estimating the survival function when there is extreme right censoring.
    Moeschberger ML; Klein JP
    Biometrics; 1985 Mar; 41(1):253-9. PubMed ID: 4005379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.